Compare BWAY & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWAY | CYRX |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | Israel | United States |
| Employees | N/A | 1100 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.8M | 419.3M |
| IPO Year | N/A | 2008 |
| Metric | BWAY | CYRX |
|---|---|---|
| Price | $16.49 | $10.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $13.25 | ★ $13.31 |
| AVG Volume (30 Days) | 144.8K | ★ 409.4K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $309.69 | $11.06 |
| Revenue Next Year | $26.21 | $8.45 |
| P/E Ratio | $81.98 | ★ $7.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.59 | $5.31 |
| 52 Week High | $26.63 | $11.45 |
| Indicator | BWAY | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.22 | 68.70 |
| Support Level | $14.56 | $9.18 |
| Resistance Level | $16.63 | $11.33 |
| Average True Range (ATR) | 0.71 | 0.41 |
| MACD | 0.41 | 0.08 |
| Stochastic Oscillator | 95.83 | 82.83 |
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.